Tesamorelin is a synthetic analogue of growth-hormone-releasing hormone (GHRH) — a 44-amino-acid peptide with an additional trans-3-hexenoic acid group on the N-terminus that confers protease resistance. Falutz and colleagues (2007, 2010) demonstrated in HIV-associated lipodystrophy that 2 mg daily SC reduced visceral adipose tissue by 15–18% over 26 weeks while sparing subcutaneous fat. Stanley et al. (2014, JAMA) confirmed durable VAT reduction and showed improvements in liver fat fraction — work that has since pulled tesamorelin into MASLD/NAFLD research lines.
For Abu Dhabi research groups — at universities along the Khalifa City corridor, biotech tenants on Yas Island, and clinical CROs operating out of the medical districts — the bottleneck has never been the science. It has been supply. Tesamorelin is a niche, temperature-sensitive lyophilised peptide. Importing single vials through customs is impractical; relying on overseas vendors with 7–14 day transit destroys cold-chain confidence. The solution most Abu Dhabi labs have settled on is sourcing from a Dubai-based research supplier that holds local stock and ships intra-emirate next day. That is the model REVIVE operates from its Dubai logistics base.
Tesamorelin binds the GHRH receptor on anterior pituitary somatotrophs, stimulating endogenous pulsatile GH release. Unlike exogenous recombinant GH, it preserves the physiological feedback loop — somatostatin still modulates the pulse amplitude, IGF-1 still provides negative feedback. The clinical signature is selective visceral fat reduction with a relatively preserved insulin-sensitivity profile, distinguishing it from direct GH administration which can worsen glucose tolerance.
Klausen et al. and subsequent GHRH-analogue work established that the physiological pulse pattern is preserved, which matters mechanistically: the muscle and fat tissue responses to pulsed GH differ from those of steady-state GH exposure. For comparative reading on GHRH versus GHRP signalling pathways, see our tesamorelin vs ipamorelin pathway comparison.
REVIVE is a Dubai-based research peptide supplier. We hold real local stock of tesamorelin 5 mg and 10 mg vials — not a drop-ship facade — and dispatch from our Dubai cold-chain facility daily. The delivery matrix across the seven emirates:
| Emirate / Area | Cut-off | Delivery window | Cold-chain |
|---|---|---|---|
| Dubai (all districts) | 16:00 GST | Same-day evening | Insulated bag, gel pack |
| Abu Dhabi — Khalifa City | 14:00 GST | Next-day before 12:00 | EPS shipper, phase-change gels |
| Abu Dhabi — Yas Island | 14:00 GST | Next-day before 14:00 | EPS shipper, phase-change gels |
| Abu Dhabi — Saadiyat | 14:00 GST | Next-day before 14:00 | EPS shipper, phase-change gels |
| Abu Dhabi — Reem / Corniche | 14:00 GST | Next-day before 12:00 | EPS shipper, phase-change gels |
| Sharjah | 14:00 GST | Next-day | Insulated bag, gel pack |
| Ajman / Umm Al Quwain | 14:00 GST | Next-day | EPS shipper, phase-change gels |
| RAK / Fujairah | 13:00 GST | 1–2 business days | EPS shipper, phase-change gels |
The 130 km Sheikh Zayed Road run between REVIVE's Dubai facility and the Abu Dhabi delivery zone takes 90 minutes off-peak, 2.5 hours at peak. Ambient temperatures during the May–October window in Abu Dhabi routinely exceed 42 C. We use insulated EPS shippers with pre-conditioned phase-change material rated for 24 hours at 2–8 C, validated quarterly with data-loggers on live shipments. Lyophilised tesamorelin powder is comparatively robust at ambient for short periods — the cold-chain is maintained as protocol for institutional traceability rather than because the molecule is fragile in powder form. Reconstituted vials are a different story; see our UAE fridge storage guide.
The reference dose from the LIPO-026 (Falutz) and Stanley trials is 2 mg daily subcutaneous. Vial math from REVIVE-supplied formats:
| Vial | BAC water | Concentration | 2 mg draw (1mL syringe) |
|---|---|---|---|
| Tesamorelin 5 mg | 2 mL | 2.5 mg/mL | 0.80 mL (80 IU) |
| Tesamorelin 5 mg | 1 mL | 5 mg/mL | 0.40 mL (40 IU) |
| Tesamorelin 10 mg | 2 mL | 5 mg/mL | 0.40 mL (40 IU) |
| Tesamorelin 10 mg | 1 mL | 10 mg/mL | 0.20 mL (20 IU) |
BAC water — bacteriostatic water with 0.9% benzyl alcohol — is the standard reconstitution diluent for multi-use vials. REVIVE supplies 3 mL BAC water vials as a companion SKU. Reconstituted tesamorelin is stable refrigerated for approximately 14 days; the 10 mg vial reconstituted with 2 mL BAC water gives a 25-day supply at 2 mg daily, which is the most common research block length.
For protocol building, see our tesamorelin visceral fat research protocol.
Many Abu Dhabi research groups run tesamorelin in parallel with other research peptides we stock — BPC-157 5 mg for tissue-repair arms, GHK-Cu 50 mg or 100 mg for connective-tissue work, MOTS-c 10 mg for mitochondrial-metabolism endpoints, NAD+ 100 mg for cellular-energy crossover protocols. Bundled orders share a single cold-chain shipment, which simplifies the logistics paperwork. For a current view of what we ship from Dubai, see our complete peptide stock list for the UAE.
REVIVE Peptides ships tesamorelin 5 mg and 10 mg vials from Dubai stock with same-day delivery in Dubai and next-day delivery to Abu Dhabi including Khalifa City, Yas Island, Saadiyat, and Reem Island. Orders placed before 14:00 GST dispatch the same evening on cold-chain courier. Buy tesamorelin UAE 24h delivery.
REVIVE uses insulated EPS shippers with phase-change gel packs validated to hold 2–8 C for 24 hours through the 130 km Dubai–Abu Dhabi corridor. The lyophilised powder itself is robust at ambient for short periods, but cold-chain is maintained as protocol for institutional buyers.
Yes. REVIVE supplies universities, clinical research organisations, and contract labs in Abu Dhabi on 30-day terms with HPLC certificates of analysis, batch traceability, and consolidated monthly invoicing. Contact the research desk for an institutional account application.
REVIVE stocks tesamorelin 5 mg and 10 mg lyophilised vials. Both are research-grade with HPLC verification above 99% purity. The 10 mg vial is the standard format for 4-week reconstitution research blocks at 2 mg daily.